Finance

Lists
TECN:SWX
Tecan Group AG
CHF 194.50
+0.05%
(+0.10) 1D
Aug 31, 10:08:28 AM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for TECN...
Open
CHF 194.40
High
CHF 195.20
Low
CHF 193.80
Mkt. cap
2.49B
Avg. vol.
52.47K
Volume
4.56K
Dividend
1.54%
Quarterly dividend
CHF 0.75
Ex-dividend date
Apr 17, 2026
52-wk high
CHF 202.00
52-wk low
CHF 110.60
EPS
-CHF 9.20
Shares outstanding
12.83M
No. of employees
3K
Open
CHF 194.40
High
CHF 195.20
Low
CHF 193.80
Mkt. cap
2.49B
Avg. vol.
52.47K
Volume
4.56K
Dividend
1.54%
Quarterly dividend
CHF 0.75
Ex-dividend date
Apr 17, 2026
52-wk high
CHF 202.00
52-wk low
CHF 110.60
EPS
-CHF 9.20
Shares outstanding
12.83M
No. of employees
3K
Profile
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics. The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in North America, Europe and APAC and maintains a sales and service network in 52 countries. In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
About Tecan Group AG
CEO-
Employees3K
Founded1980
HeadquartersMännedorf, Zurich, Switzerland
SectorHealth care
Websitetecan.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
221.50M
221.50M
213.76M
213.76M
Cost of goods sold
145.72M
145.72M
141.29M
141.29M
Cost of revenue
145.72M
145.72M
141.29M
141.29M
Research and development expenses
15.77M
15.77M
16.12M
16.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.44M
48.44M
47.13M
47.13M
Operating expense
64.86M
64.86M
63.58M
63.58M
Total operating expenses
210.58M
210.58M
204.87M
204.87M
Operating income
10.92M
10.92M
8.89M
8.89M
Other non operating income
-226.50K
-226.50K
-
-
EBT including unusual items
-62.19M
-62.19M
7.87M
7.87M
EBT excluding unusual items
9.47M
9.47M
7.87M
7.87M
Income tax expense
2.10M
2.10M
1.74M
1.74M
Effective tax rate
-3.37%
-3.37%
22.05%
22.05%
Other operating expenses
649.50K
649.50K
328.00K
328.00K
Net income
-64.29M
-64.29M
6.14M
6.14M
Net profit margin
-29.02%
-29.02%
2.87%
2.87%
Earnings per share
-
-
-
-
Interest and investment income
616.00K
616.00K
590.00K
590.00K
Interest expense
-664.00K
-664.00K
-648.50K
-648.50K
Net interest expenses
-48.00K
-48.00K
-58.50K
-58.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
16.31M
16.31M
20.27M
20.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps